Have a query? Get in touch 01 249 3200
Make a referral Get help and support Go to Your Portal

Menu

Worth the Weight? Olanzapine Prescribing in Schizophrenia. A Review of Weight Gain and Other Cardiometabolic Side Effects of Olanzapine

Fitzgerald I, O'Dwyer S, Brooks M, Sahm L, Crowley E and Ní Dhubhlaing C

Worth the Weight? Olanzapine Prescribing in Schizophrenia. A Review of Weight Gain and Other Cardiometabolic Side Effects of Olanzapine. Front. Psychiatry 12:730769. doi: 10.3389/fpsyt.2021.730769

Read

Group Radical Openness: A Feasibility Study

Booth R; Egan R; Long E; Mcelvaney J

Group Radical Openness: A Feasibility Study. Counselling and Psychotherapy Research. 2021. 1-12. DOI:10.1002/capr.12480

Read

Vascular endothelial growth factor plasma levels in depression and following electroconvulsive therapy.

Vascular endothelial growth factor plasma levels in depression and following electroconvulsive therapy. Eur Arch Psychiatry Clin Neurosci Jul 2. [Epub ahead of print] PMID: 29968119

Read

From molecules to mind: mechanisms of action of electroconvulsive therapy.

Ryan KM, McLoughlin DM

From molecules to mind: mechanisms of action of electroconvulsive therapy. Acta Psychiatr Scand Sep;138(3):177-179. doi: 10.1111/acps.12951. PMID: 30295935

Read

Peripheral blood SIRT1 mRNA levels in depression and treatment with electroconvulsive therapy.

McGrory CL, Ryana KM, Kolshus E, Finnegan M, McLoughlin DM

Peripheral blood SIRT1 mRNA levels in depression and treatment with electroconvulsive therapy. Eur Neuropsychopharmacol 28: 10115-1023. PMID: 30017261

Read

BDNF plasma levels and genotype in depression and the response to electroconvulsive therapy.

Ryan KM, Dunne R, McLoughlin DM

BDNF plasma levels and genotype in depression and the response to electroconvulsive therapy. Brain Stimul Sep - Oct;11(5):1123-1131. PMID: 29802070

Read

© Copyright 2022 St. Patrick’s Mental Health Services